Expression Table for this CRE
| CNhs14078 | amygdala, newborn, donor10223 | 6.3 |
| CNhs14434 | COBL-a rinderpest infection, 48hr, biol_rep3 | 5.3 |
| CNhs13839 | iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 2.4 |
| CNhs11990 | Smooth Muscle Cells - Subclavian Artery, donor2 | 2.2 |
| CNhs12698 | K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 0.9 |
| CNhs11844 | acantholytic squamous carcinoma cell line:HCC1806 | 0.9 |
| CNhs13919 | CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3 | 0.9 |
| CNhs14525 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3 | 0.8 |
| CNhs11835 | osteoclastoma cell line:Hs 706.T | 0.5 |
| CNhs13637 | Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h) | 0.5 |
| CNhs14060 | iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2 | 0.4 |
| CNhs12366 | mesenchymal precursor cell - bone marrow, donor1 | 0.3 |
| CNhs13603 | mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1 | 0.3 |
| CNhs13371 | Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38) | 0.3 |
| CNhs13404 | Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2) | 0.3 |
| SRX6586243 | CNhi10328_THP-1_Non-treatment (DMSO)-48h_rep3 | 0.2 |
| CNhs14580 | Myoblast differentiation to myotubes, day03, control donor3 | 0.2 |
| CNhs12798 | K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3 | 0.2 |
| CNhs13107 | Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9) | 0.2 |
| CNhs12310 | medial frontal gyrus, adult, donor10252 | 0.2 |
| CNhs12351 | testicular germ cell embryonal carcinoma cell line:NEC14 | 0.2 |
| CNhs12091 | Urothelial Cells, donor2 | 0.2 |
| CNhs14522 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3 | 0.2 |
| CNhs14057 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3 | 0.1 |
| CNhs12658 | MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2 | 0.1 |
| CNhs13617 | mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3 | 0.1 |
| SRX6586259 | CNhi10332.Z_THP-1_siRNA-negative control-48h_rep2 | 0.1 |
| SRX6586330 | CNhi10316_MCF-7_Simvastatin-30 uM-6h_rep3 | 0.1 |
| CNhs13285 | Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10) | 0.1 |
| CNhs11766 | trachea, fetal, donor1 | 0.1 |
| SRX6586241 | CNhi10328_THP-1_Atrovastatin-30 uM-48h_rep2 | 0.1 |
| CNhs11350 | Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1 | 0.1 |
| SRX6586335 | CNhi10317_MCF-7_Non-treatment (DMSO)-48h_rep5 | 0.1 |
| SRX6586244 | CNhi10328_THP-1_Non-treatment (DMSO)-48h_rep4 | 0.1 |
| SRX6586245 | CNhi10328_THP-1_Non-treatment (DMSO)-48h_rep5 | 0.0 |
| SRX6586334 | CNhi10317_MCF-7_Non-treatment (DMSO)-48h_rep4 | 0.0 |
| SRX6586333 | CNhi10317_MCF-7_Non-treatment (DMSO)-48h_rep3 | 0.0 |
| SRX6586240 | CNhi10328_THP-1_Atrovastatin-30 uM-48h_rep1 | 0.0 |
| SRX6586242 | CNhi10328_THP-1_Atrovastatin-30 uM-48h_rep3 | 0.0 |
| SRX6586332 | CNhi10317_MCF-7_Non-treatment (DMSO)-48h_rep2 | 0.0 |
| ERX10345068 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345069 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345070 | human post-mortem brain tissue of the frontal lobe_patients with FTD-MAPT | 0 |
| ERX10345071 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345072 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345073 | human post-mortem brain tissue of the frontal lobe_patients with FTD-MAPT | 0 |
| ERX10345074 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345075 | human post-mortem brain tissue of the frontal lobe_patients with FTD-C9 | 0 |
| ERX10345076 | human post-mortem brain tissue of the frontal lobe_patients with FTD-MAPT | 0 |
| ERX10345077 | human post-mortem brain tissue of the frontal lobe_patients with FTD-MAPT | 0 |